Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance (NCT07636148) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
France, Netherlands2,000 participantsStarted 2026-07-01
Plain-language summary
This study collects data from patients undergoing minimally invasive, image-guided cancer treatments at participating hospitals in the Netherlands and France. All treatments are performed as standard clinical care and include procedures such as tumor ablation and catheter-based treatments of cancer in the liver, kidney, lung, and bone.
During these procedures, a spectral angio-CT system is used for image guidance. This advanced CT scanner automatically captures additional imaging information beyond what is used in routine clinical decision-making. The goal of this study is to investigate how this additional imaging information is associated with treatment outcomes, and how it can be used in the future to improve treatment planning, procedural guidance, and prediction of treatment results.
No experimental interventions are performed. Participation does not alter the treatment or follow-up patients receive. Data are collected from medical records and imaging systems and stored securely for analysis.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years;
* Undergoing a clinically indicated IO procedure with a percutaneous or transarterial approach for solid tumors;
* Use of spectral angio-CT image guidance as part of standard care;
* Written confirmed consent.
Exclusion Criteria:
* Patients who are declared incapacitated;
* Patients suffering from psychic disorders that make a comprehensive judgement impossible.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This registry uses something called Spectral Angio-CT image guidance during minimally invasive procedures — can you explain what that technology actually does differently compared to standard image-guided tumor treatments, and whether it might offer any advantage for my specific cancer?
2Since this is listed as a registry rather than a treatment trial, does participating mean I'm actually receiving an experimental treatment, or is this mainly about collecting data on procedures that might already be recommended for me anyway?
3The trial isn't recruiting yet — how long do you think it might be before it opens, and should we be making treatment decisions now rather than waiting to see if I could participate?
4The primary outcome being tracked is 'local tumor control' — what does that mean in practical terms for my situation, and how would my own results be monitored and shared with me during the registry?
5This registry covers a wide range of cancers including my diagnosis — are there standard, already-approved minimally invasive options I should consider first, and how would you compare those to what's being studied here?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.